Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis

Anticancer Research

Volumn 26, Issue 1 B, 2006, Pages 723-727

  Schuetz, Matthias ^a   Beheshti, Mohsen ^a   Oezer, Semun ^a   Novotny, Clemens ^a   Paul, Matthias ^a   Hofmann, Andrea ^a   Bieglmayer, Christian ^a   Niederle, Bruno ^a   Kletter, Kurt ^a   Dudczak, Robert ^a   Karanikas, Georgios ^a   Pirich, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

C cell hyperplasia; Calcitonin; Hashimoto's thyroiditis; Medullary thyroid carcinoma; Pentagastrin stimulation test

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ADULT; AGED; ARTICLE; ASSAY; CALCITONIN BLOOD LEVEL; CANCER DIAGNOSIS; CELL HYPERPLASIA; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; HASHIMOTO DISEASE; HUMAN; LABORATORY TEST; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CARCINOMA, MEDULLARY; DNA, NEOPLASM; FEMALE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 32144446457     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Seth R, Motte P, Kehely A, Wimalawansa SJ, Self CH, Bellet D, Bohuon C and MacIntyre I: Sensitive and specific two-site enzyme immunoassay for human calcitonin using monoclonal antibodies. J Endocrinol 119: 351-357, 1988.
2. Barbot N, Calmettes C, Schuffenecker I, Saint-Andre JP, Franc B, Rohmer V, Jallet P and Bigorgne JC: Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 78: 114-120, 1994.
3. Marsh DJ, McDowall D, Hyland VJ, Andrew SD, Schnitzler M, Gaskin EL, Nevell DF, Diamond T, Delbridge L, Clifton-Bligh P and Robinson BG: The identification of the positive responses to pentagastrin stimulation test in ret mutation negative members of MEN 2° families. Clin Endocrinol (Oxf) 44: 213-220, 1996.
4. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, DiCoscio G, Miccoli P and Pinchera A: Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78: 826-829, 1994.
5. Rieu M, Lame C-C, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL and Fombeur JP: Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf) 42: 453-460, 1995.
6. Scheuba Ch, Kaserer K, Weinhäusel A, Pandev R, Kaider A, Passler Ch, Prager G, Vierhapper H, Haas O and Niederle B: Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126: 1089-1096, 1999.
7. Kaserer K, Scheuba Ch, Neuhold N, Weinhäusel A, Vierhapper H, Haas O and Niederle B: C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22: 722-728, 1998.
8. Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, Niederle B, Dudczak R and Pirich C: Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89: 515-519, 2004.
9. Bieglmayer C, Niederle B and Vierhapper H: Interference causes false high calcitonin levels with a commercial assay. J Endocr Invest 25: 197, 2002.
10. Rosai J, Caracangiu ML and DeLellis RA: Atlas of Tumor Pathology: Tumors of the Thyroid Gland, 3rd series. Washington DC: Armed Forces Institute of Pathology, pp. 247-258, 1992.
11. Fink M, Weinhäusl A, Niederle B and Haas OA: Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. Study Group Multiple Endocrine Neoplasia Austria (SMENA). Int J Cancer 69: 312-316, 1996.
12. Kaserer K, Scheuba Ch, Neuhold N, Weinhäusel A, Haas O, Vierhapper H and Niederle B: Sporadic versus familial medullary thyroid microcarcinoma. Am J Surg Pathol 25: 1245-1251, 2001.
13. Guyetant S, Wion-Barbot N, Rousselet MC, Franc B, Bigorgne JC and Saint-Andre JP: C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. Hum Pathol 25: 514-521, 1994.
14. Libbey NP, Nowakowski KJ and Tucci JR: C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis. Am J Surg Pathol 13: 987-989, 1989.
15. Weiss LM, Weinberg DS and Warhol MJ: Medullary carcinoma arising in a thyroid with Hashimoto's disease. Am J Clin Pathol 80: 534-538, 1983.
16. Barbot N, Guyetant S, Beldent V, Akrass A, Cerf I, Perdrisot R and Bigorgne JC: Chronic autoimmune thyroiditis and C-cell hyperplasia. Study of calcitonin secretion in 24 patients. Ann Endocrinol 52: 109-112, 1991.
17. Perry A, Molberg K and Albores-Saavedra J: Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer 77: 750-756, 1996.
18. Niccoli P, Wion-Barbot N, Caron Ph, Henry JF, De Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B and the French Medullary study Group: Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 82: 338-341, 1997.
19. Scopsi L, Di Palma S, Ferrari C, Holst JJ, Rehfeld JF and Rilke F: C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin. Mod Pathol 4: 297-304, 1991.
20. Pastolero GC, Coire CI and Asa SL: Concurrent medullary and papillary carcinomas of thyroid with lymph node metastases. A collision phenomenon. Am J Surg Pathol 20: 245-250, 1996.
21. Elisei R, Cosci B, Romei C, Bottici V, Sculli M, Lari R, Barale R, Pacini F and Pinchera A: RET Exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. J Clin Endocrinol Metab 89: 3579-3584, 2004.
22. Franc S, Niccoli-Sire P, Cohen R, Bardetz S, Maes B, Murat A, Krivitzky A, Modigliani S and the French Medullary Study Group: Complete surgical lymph node resection does not prevent authentic recurrence of medullary thyroid carcinoma. Clin Endocrinol 55: 403-409, 2001.